Details of the Drug Reposition

General Information of This Drug (ID: DMGJR0Y)

Drug Name
VB-201   DMGJR0Y
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Arteriosclerosis DISK5QGC BD40 Phase 2 [1]
Psoriasis vulgaris DIS6M7AN EA90 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis. Clin Exp Immunol. 2014 Jan;175(1):126-37.
2 ClinicalTrials.gov (NCT01001468) Study to Assess VB-201 in Patients With Psoriasis. U.S. National Institutes of Health.